Skip to content
Monday, November 9, 2026
UpdateHub360

The Zimbabwean Government Turns Down ‘Unbalanced’ US Health Aid Agreement Over Data Fears

Medical funding illustration
The proposed American funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of the United States' request for sensitive biological samples.

The decision came to light after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".

A government representative later explained that the United States was requesting health data for scientific study and profit while was not willing to guarantee the benefits from any future treatments.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has urged further dialogue to secure a agreement agreeable to both sides so the country's vital HIV treatment initiative can proceed.

Wider Background

This rejection comes after a similar situation in Kenya, where a court suspended a similar deal with the US following concerns were raised about the safety of citizens' medical information.

After returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost openness and responsibility.

Based on statements, 16 African countries have so far agreed to these new health pacts, representing over $18.3bn in committed funds.

Details of the Declined Agreement

The money for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," his statement read.

"In essence, our nation would supply the raw materials for scientific discovery without any assurance that the end products would be available to our citizens if a new disease outbreak emerge."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining frameworks already set up through the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This mechanism is designed to ensure that when a country contributes its information, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."

The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage continued discussions with our US partners on how subsequent co-operation could be designed in a way that honours the independence and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but recommended that negotiations must proceed since much of the country's HIV programmes were funded by external financing.

"Where technical issues exist, such as those involving information security or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," it added.

The situation underscores the complex debate between receiving vital foreign assistance and protecting a country's data in an ever more data-driven world.

By

William Wong

A tech journalist with over a decade of experience covering emerging technologies and consumer electronics.

UpdateHub360

Type to search articles.